NDC 67046-1081-03 - Cefuroxime Axetil
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 67046-1081
- Requested NDC
- 67046-1081-03
- Package NDCs from labels
- 67046-1081-3, 67046-1081-03
- Manufacturer
- Coupler LLC
- Effective date
- 2025-01-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cefuroxime Axetil - Coupler LLC | Coupler LLC | 2025-01-21 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67046-1081-3 | Cefuroxime Axetil | 30 in 1 BLISTER PACK | TABLET | 30 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 67046-1081 | CEFUROXIME AXETIL TABLET [COUPLER LLC] | 1 | Current NDC, 1 package rows | 20250125_2c3a502f-8e72-c4d2-e063-6394a90a6fa5.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefuroxime Axetil | CEFUROXIME AXETIL | REMEDYREPACK INC. | 76cec54f-d167-4298-951b-5411a3c47f4a | 2026-08-05 | Warnings, Adverse reactions | ANDA065308 309098 Z49QDT0J8Z |
| Cefuroxime Axetil | CEFUROXIME AXETIL | Redpharm Drug | 56cb6f42-9ae1-38e7-e063-6294a90a3feb | 2026-07-31 | Warnings, Adverse reactions | ANDA065308 309097 Z49QDT0J8Z |
| Cefuroxime Axetil | CEFUROXIME AXETIL | A-S Medication Solutions | 85cdd8d9-557e-4d15-855a-027e7809cf64 | 2026-05-14 | Warnings, Adverse reactions | ANDA065308 309098 Z49QDT0J8Z |
| Cefuroxime Axetil | CEFUROXIME AXETIL | A-S Medication Solutions | d14d4184-3e29-43cd-8046-658699c70f03 | 2026-05-14 | Warnings, Adverse reactions | ANDA065308 309097 Z49QDT0J8Z |
| Cefuroxime axetil | CEFUROXIME AXETIL | Golden State Medical Supply, Inc. | bb7955fe-5111-1662-e053-2a95a90a85a1 | 2026-04-23 | Warnings, Adverse reactions | 309098 309097 Z49QDT0J8Z |
| Cefuroxime axetil | CEFUROXIME AXETIL | NuCare Pharmaceuticals, Inc. | 4e4426a4-0ca9-dad5-e063-6294a90a5fdb | 2026-03-30 | Warnings, Adverse reactions | 309098 Z49QDT0J8Z |
| Cefuroxime Axetil | CEFUROXIME AXETIL | PD-Rx Pharmaceuticals, Inc. | a84ac4ed-c268-4e9f-9df8-256e0a64cd16 | 2026-03-18 | Warnings, Adverse reactions | ANDA065308 309097 Z49QDT0J8Z |
| Cefuroxime Axetil | CEFUROXIME AXETIL | A-S Medication Solutions | a940ba01-2b53-4947-9019-d3d8f4e9ad80 | 2026-01-23 | Warnings, Adverse reactions | ANDA065308 309097 Z49QDT0J8Z |
| Cefuroxime axetil | CEFUROXIME AXETIL | Advanced Rx of Tennessee, LLC | 48d96608-d3da-b512-e063-6294a90a07d5 | 2026-01-16 | Warnings, Adverse reactions | 309098 Z49QDT0J8Z |
| Cefuroxime axetil | CEFUROXIME AXETIL | Redpharm Drug | 3744f28c-c7e1-259c-e063-6294a90a10ed | 2025-12-11 | Warnings, Adverse reactions | 309098 Z49QDT0J8Z |
| Cefuroxime axetil | CEFUROXIME AXETIL | PD-Rx Pharmaceuticals, Inc. | 2af8f061-c0e1-3a1c-e054-00144ff8d46c | 2025-10-15 | Warnings, Adverse reactions | 309097 Z49QDT0J8Z |
| Cefuroxime axetil | CEFUROXIME AXETIL | PD-Rx Pharmaceuticals, Inc. | 2af94304-8118-41c7-e054-00144ff8d46c | 2025-10-15 | Warnings, Adverse reactions | 309097 Z49QDT0J8Z |
| Cefuroxime Axetil | CEFUROXIME AXETIL | A-S Medication Solutions | aa6685c1-51ed-466a-ae7f-89a82986a7b1 | 2025-10-08 | Warnings, Adverse reactions | ANDA065308 309098 Z49QDT0J8Z |
| Cefuroxime Axetil | CEFUROXIME AXETIL | A-S Medication Solutions | 119c4d09-2324-498f-9318-1f8db49ad4b6 | 2025-10-08 | Warnings, Adverse reactions | ANDA065308 309097 Z49QDT0J8Z |
| Cefuroxime axetil | CEFUROXIME AXETIL | Ascend Laboratories, LLC | dd11e4b9-7730-4d3a-81ca-16f15de09759 | 2025-10-03 | Warnings, Adverse reactions | 309098 309097 Z49QDT0J8Z |
| Cefuroxime Axetil | CEFUROXIME AXETIL | NuCare Pharmaceuticals, Inc. | 3f92c452-18b4-5af8-e063-6394a90aaa53 | 2025-09-24 | Warnings, Adverse reactions | ANDA065308 309098 Z49QDT0J8Z |
| Cefuroxime axetil | CEFUROXIME AXETIL | Major Pharmaceuticals | 44e1fb4d-4b61-40da-9974-0bd2006eb828 | 2025-09-12 | Warnings, Adverse reactions | 309097 Z49QDT0J8Z |
| Cefuroxime axetil | CEFUROXIME AXETIL | American Health Packaging | f38418a7-dd90-4f20-b747-7ac086c53015 | 2025-08-06 | Warnings, Adverse reactions | 309098 309097 Z49QDT0J8Z |
| Cefuroxime Axetil | CEFUROXIME AXETIL | Preferred Pharmaceuticals Inc. | bc9200d2-4a6d-4847-ba85-8e9d378390de | 2025-07-31 | Warnings, Adverse reactions | ANDA065308 309098 Z49QDT0J8Z |
| Cefuroxime axetil | CEFUROXIME AXETIL | PD-Rx Pharmaceuticals, Inc. | 15cabe73-f39d-4798-a840-115fe94f8f96 | 2025-03-13 | Warnings, Adverse reactions | 309098 Z49QDT0J8Z |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.